Marina Ruggeri

1.4k total citations
21 papers, 464 citations indexed

About

Marina Ruggeri is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Marina Ruggeri has authored 21 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Hematology and 5 papers in Oncology. Recurrent topics in Marina Ruggeri's work include Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Marina Ruggeri is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Marina Ruggeri collaborates with scholars based in Italy, Switzerland and United States. Marina Ruggeri's co-authors include Davide Brunelli, Luca Benini, Mario Boccadoro, Pellegrino Musto, Francesca Gay, Paola Omedè, Antonio Palumbo, Antonio Palumbo, Sara Bringhen and Benedetto Bruno and has published in prestigious journals such as Journal of Clinical Oncology, Blood and ACS Nano.

In The Last Decade

Marina Ruggeri

20 papers receiving 459 citations

Peers

Marina Ruggeri
Indrajeet Singh United States
Xiaorong Ma China
Wenli Zhao China
Anna Kron Germany
Xiaolei Wei China
Myung-Hoon Lee South Korea
Zhenya Ding China
Maria V. Yusenko Germany
Jinghong Chen China
Indrajeet Singh United States
Marina Ruggeri
Citations per year, relative to Marina Ruggeri Marina Ruggeri (= 1×) peers Indrajeet Singh

Countries citing papers authored by Marina Ruggeri

Since Specialization
Citations

This map shows the geographic impact of Marina Ruggeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Ruggeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Ruggeri more than expected).

Fields of papers citing papers by Marina Ruggeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Ruggeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Ruggeri. The network helps show where Marina Ruggeri may publish in the future.

Co-authorship network of co-authors of Marina Ruggeri

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Ruggeri. A scholar is included among the top collaborators of Marina Ruggeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Ruggeri. Marina Ruggeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gabbani, Alessio, Marco Carlotti, Marina Ruggeri, et al.. (2022). Invisible Thermoplasmonic Indium Tin Oxide Nanoparticle Ink for Anti-counterfeiting Applications. ACS Applied Materials & Interfaces. 14(30). 35276–35286. 27 indexed citations
2.
Gabbani, Alessio, Marina Ruggeri, Valentina Cappello, et al.. (2022). Rapid self-healing in IR-responsive plasmonic indium tin oxide/polyketone nanocomposites. Journal of Materials Chemistry A. 10(24). 12957–12967. 16 indexed citations
3.
Oliva, Stefania, Lorenzo De Paoli, Marina Ruggeri, et al.. (2021). A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma. Annals of Hematology. 100(2). 437–443. 8 indexed citations
4.
Grazianetti, Carlo, Christian Martella, Marina Ruggeri, et al.. (2021). Hydrophilic Character of Single-Layer MoS2 Grown on Ag(111). The Journal of Physical Chemistry C. 125(17). 9479–9485. 13 indexed citations
5.
Oliva, Stefania, Elisa Genuardi, Angelo Belotti, et al.. (2020). Multiparameter flow cytometry (MFC) and next generation sequencing (NGS) for minimal residual disease (MRD) evaluation: Results of the FORTE trial in newly diagnosed multiple myeloma (MM).. Journal of Clinical Oncology. 38(15_suppl). 8533–8533. 14 indexed citations
6.
D’Agostino, Mattia, Marina Ruggeri, Sara Aquino, et al.. (2020). Impact of Gain and Amplification of 1q in Newly Diagnosed Multiple Myeloma Patients Receiving Carfilzomib-Based Treatment in the Forte Trial. Blood. 136(Supplement 1). 38–40. 29 indexed citations
7.
Batchelor, Lucinda K., Gabriele Agonigi, Simona Braccini, et al.. (2019). Anticancer Potential of Diiron Vinyliminium Complexes. Chemistry - A European Journal. 25(65). 14739–14739. 4 indexed citations
8.
Lia, Giuseppe, Andrea Evangelista, Lucia Brunello, et al.. (2019). Long-Term Thymic Function and Reconstitution of the T Cell Compartment after T Cell-Replete Haplo-Identical Allografting. Biology of Blood and Marrow Transplantation. 25(3). S331–S331. 3 indexed citations
9.
Batchelor, Lucinda K., Gabriele Agonigi, Simona Braccini, et al.. (2019). Anticancer Potential of Diiron Vinyliminium Complexes. Chemistry - A European Journal. 25(65). 14801–14816. 40 indexed citations
10.
Saraci, Elona, Milena Gilestro, Marina Ruggeri, et al.. (2017). Relevance of sample preparation for flow cytometry. International Journal of Laboratory Hematology. 40(2). 152–158. 3 indexed citations
11.
Saraci, Elona, Milena Gilestro, Valter Gattei, et al.. (2015). Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents. Cytometry Part B Clinical Cytometry. 90(1). 81–90. 43 indexed citations
12.
Foglietta, Myriam, Barbara Castella, Sara Mariani, et al.. (2014). The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status. Haematologica. 99(10). 1605–1610. 27 indexed citations
13.
Caltagirone, S, Marina Ruggeri, Simona Aschero, et al.. (2014). Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. Haematologica. 99(10). 1611–1617. 17 indexed citations
14.
Boccadoro, Mario, Federica Cavallo, Francesco Di Raimondo, et al.. (2013). Melphalan/prednisone/lenalidomide (MPR) versus high-dose melphalan and autologous transplantation (MEL200) plus lenalidomide maintenance or no maintenance in newly diagnosed multiple myeloma (MM) patients.. Journal of Clinical Oncology. 31(15_suppl). 8509–8509. 16 indexed citations
15.
Brunelli, Davide, et al.. (2011). An effective multi-source energy harvester for low power applications. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 1–6. 72 indexed citations
16.
Palumbo, Antonio, Francesca Gay, Sara Bringhen, et al.. (2008). Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma. Annals of Oncology. 19(6). 1160–1165. 85 indexed citations
17.
Boccadoro, Mario, Sara Galimberti, Maria Teresa Petrucci, et al.. (2008). Melphalan 200 Mg/m2 (Mel200) Versus Melphalan 100 Mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients: A Prospective, Randomized Phase III Study. Blood. 112(11). 3316–3316.
18.
Ruggeri, Marina, et al.. (1996). [Henoch-Schonlein purpura. Considerations about 95 pediatric cases].. PubMed. 48(5). 201–8. 3 indexed citations
19.
Palareti, Gualtiero, Cesare Manotti, Armando Tripodi, et al.. (1991). Fibrinogen assays: a collaborative study of six different methods. C.I.S.M.E.L. Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio.. PubMed. 37(5). 714–9. 40 indexed citations
20.
Barbi, Maria, et al.. (1985). [Congenital cytomegalovirus infections in a neonatal pathology unit].. PubMed. 64(4). 262–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Indrajeet Singh Breakdown of academic impact, for papers by Xiaorong Ma Breakdown of academic impact, for papers by Wenli Zhao Breakdown of academic impact, for papers by Anna Kron Breakdown of academic impact, for papers by Xiaolei Wei Breakdown of academic impact, for papers by Myung-Hoon Lee Breakdown of academic impact, for papers by Zhenya Ding Breakdown of academic impact, for papers by Maria V. Yusenko Breakdown of academic impact, for papers by Jinghong Chen
Rankless by CCL
2026